Insiders Updates
NAMS’s latest rating updates from top analysts.
NewAmsterdam Pharma Company NV’s filing revealed that its Chief Operating Officer Kling Douglas F unloaded Company’s shares for reported $1.08
Menu
NewAmsterdam Pharma Company NV’s filing revealed that its Chief Operating Officer Kling Douglas F unloaded Company’s shares for reported $1.08
NewAmsterdam Pharma Company NV’s filing revealed that its Affiliate NAP PoolCo B.V. acquired Company’s shares for reported $30.9 million on
NewAmsterdam Pharma Company NV’s recently made public that its Director Topper James N acquired Company’s shares for reported $46454.0 on
NewAmsterdam Pharma Company NV’s filing revealed that its Director Topper James N acquired Company’s shares for reported $46454.0 on Jun
NewAmsterdam Pharma Company NV’s recent filing unveils that its Chief Operating Officer Kling Douglas F unloaded Company’s shares for reported